ScienceAlert on MSN
Ozempic-like drugs may increase risk of bone and joint conditions
(Viktoriya Skorikova/Moment/Getty Images) GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent ...
The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, has expanded rapidly among patients ...
Morning Overview on MSN
Study suggests GLP-1 drugs may raise fracture and tendon injury risk
A peer-reviewed study of more than 46,000 older adults with type 2 diabetes found that patients who started GLP-1 receptor agonist drugs faced an 11 percent higher risk of fragility fractures compared ...
Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health, today ...
WASHINGTON — After more than a decade, the American College of Rheumatology has developed new draft guidance for the use of musculoskeletal ultrasound (MSUS) to help with diagnosis, monitoring, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results